相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations
Robert Shenkar et al.
GENETICS IN MEDICINE (2015)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
KRIT1 Protein Depletion Modifies Endothelial Cell Behavior via Increased Vascular Endothelial Growth Factor (VEGF) Signaling
Peter V. DiStefano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling
Nan Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
EndMT contributes to the onset and progression of cerebral cavernous malformations
Luigi Maddaluno et al.
NATURE (2013)
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
Evrim Gurpinar et al.
FRONTIERS IN ONCOLOGY (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
Gian Paolo Fadini et al.
CIRCULATION RESEARCH (2012)
Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
Marie-Helene Teiten et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype
Damian Medici et al.
SEMINARS IN CANCER BIOLOGY (2012)
Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
David A. McDonald et al.
STROKE (2012)
Wnt Signaling in Cancer
Paul Polakis
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
Gwenola Boulday et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The Wnt/β-Catenin Pathway Modulates Vascular Remodeling and Specification by Upregulating DII4/Notch Signaling
Monica Corada et al.
DEVELOPMENTAL CELL (2010)
Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling
Angela J. Glading et al.
DISEASE MODELS & MECHANISMS (2010)
CCM1 regulates vascular-lumen organization by inducing endothelial polarity
Maria Grazia Lampugnani et al.
JOURNAL OF CELL SCIENCE (2010)
Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development
Yun He et al.
SCIENCE SIGNALING (2010)
Evaluating Strategies for the Treatment of Cerebral Cavernous Malformations
Dean Y. Li et al.
STROKE (2010)
Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis
Richard Daneman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Wnt/β-catenin signaling controls development of the blood-brain barrier
Stefan Liebner et al.
JOURNAL OF CELL BIOLOGY (2008)
Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5
Andrea Taddei et al.
NATURE CELL BIOLOGY (2008)
Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature
Jan M. Stenman et al.
SCIENCE (2008)
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions
Angela Glading et al.
JOURNAL OF CELL BIOLOGY (2007)
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling
XC He et al.
NATURE GENETICS (2004)
β-Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse
S Liebner et al.
JOURNAL OF CELL BIOLOGY (2004)
Wnt signaling controls the phosphorylation status of β-catenin
M van Noort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations
RE Clatterbuck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
分享论文
